Concurrent Clade I and Clade II Monkeypox Virus Circulation, Cameroon, 1979-2022
During 1979-2022, Cameroon recorded 32 laboratory-confirmed mpox cases among 137 suspected mpox cases identified by the national surveillance network. The highest positivity rate occurred in 2022, indicating potential mpox re-emergence in Cameroon. Both clade I (n = 12) and clade II (n = 18) monkeypox virus (MPXV) were reported, a unique feature of mpox in Cameroon. The overall case-fatality ratio of 2.2% was associated with clade II. We found mpox occurred only in the forested southern part of the country, and MPXV phylogeographic structure revealed a clear geographic separation among concurrent circulating clades. Clade I originated from eastern regions close to neighboring mpox-endemic countries in Central Africa; clade II was prevalent in western regions close to West Africa. Our findings suggest that MPXV re-emerged after a 30-year lapse and might arise from different viral reservoirs unique to ecosystems in eastern and western rainforests of Cameroon.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Emerging infectious diseases - 30(2024), 3 vom: 27. März, Seite 432-443 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Djuicy, Delia D [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 26.02.2024 Date Revised 02.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.3201/eid3003.230861 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368146073 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368146073 | ||
003 | DE-627 | ||
005 | 20240302232528.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240208s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3201/eid3003.230861 |2 doi | |
028 | 5 | 2 | |a pubmed24n1314.xml |
035 | |a (DE-627)NLM368146073 | ||
035 | |a (NLM)38325363 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Djuicy, Delia D |e verfasserin |4 aut | |
245 | 1 | 0 | |a Concurrent Clade I and Clade II Monkeypox Virus Circulation, Cameroon, 1979-2022 |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.02.2024 | ||
500 | |a Date Revised 02.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a During 1979-2022, Cameroon recorded 32 laboratory-confirmed mpox cases among 137 suspected mpox cases identified by the national surveillance network. The highest positivity rate occurred in 2022, indicating potential mpox re-emergence in Cameroon. Both clade I (n = 12) and clade II (n = 18) monkeypox virus (MPXV) were reported, a unique feature of mpox in Cameroon. The overall case-fatality ratio of 2.2% was associated with clade II. We found mpox occurred only in the forested southern part of the country, and MPXV phylogeographic structure revealed a clear geographic separation among concurrent circulating clades. Clade I originated from eastern regions close to neighboring mpox-endemic countries in Central Africa; clade II was prevalent in western regions close to West Africa. Our findings suggest that MPXV re-emerged after a 30-year lapse and might arise from different viral reservoirs unique to ecosystems in eastern and western rainforests of Cameroon | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Cameroon | |
650 | 4 | |a Central Africa | |
650 | 4 | |a MPXV | |
650 | 4 | |a Mpox | |
650 | 4 | |a West Africa | |
650 | 4 | |a clade I | |
650 | 4 | |a clade II | |
650 | 4 | |a concurrent circulation | |
650 | 4 | |a epidemiology | |
650 | 4 | |a forest | |
650 | 4 | |a geographic segregation | |
650 | 4 | |a monkeypox virus | |
650 | 4 | |a surveillance | |
650 | 4 | |a surveillance system | |
650 | 4 | |a viruses | |
650 | 4 | |a zoonoses | |
700 | 1 | |a Sadeuh-Mba, Serge A |e verfasserin |4 aut | |
700 | 1 | |a Bilounga, Chanceline N |e verfasserin |4 aut | |
700 | 1 | |a Yonga, Martial G |e verfasserin |4 aut | |
700 | 1 | |a Tchatchueng-Mbougua, Jules B |e verfasserin |4 aut | |
700 | 1 | |a Essima, Gael D |e verfasserin |4 aut | |
700 | 1 | |a Esso, Linda |e verfasserin |4 aut | |
700 | 1 | |a Nguidjol, Inès M E |e verfasserin |4 aut | |
700 | 1 | |a Metomb, Steve F |e verfasserin |4 aut | |
700 | 1 | |a Chebo, Cornelius |e verfasserin |4 aut | |
700 | 1 | |a Agwe, Samuel M |e verfasserin |4 aut | |
700 | 1 | |a Ankone, Placide A |e verfasserin |4 aut | |
700 | 1 | |a Ngonla, Firmin N N |e verfasserin |4 aut | |
700 | 1 | |a Mossi, Hans M |e verfasserin |4 aut | |
700 | 1 | |a Etoundi, Alain G M |e verfasserin |4 aut | |
700 | 1 | |a Eyangoh, Sara I |e verfasserin |4 aut | |
700 | 1 | |a Kazanji, Mirdad |e verfasserin |4 aut | |
700 | 1 | |a Njouom, Richard |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Emerging infectious diseases |d 1995 |g 30(2024), 3 vom: 27. März, Seite 432-443 |w (DE-627)NLM088704254 |x 1080-6059 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2024 |g number:3 |g day:27 |g month:03 |g pages:432-443 |
856 | 4 | 0 | |u http://dx.doi.org/10.3201/eid3003.230861 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2024 |e 3 |b 27 |c 03 |h 432-443 |